MUC5B and systemic sclerosis: Interestingly, these studies demonstrated that there is no association between this variant and the pulmonary fibrosis present in conditions like systemic sclerosis and sarcoidosis, suggesting a specific role for the studied MUC5B polymorphism in IPF pathogenesis.